Preparing for Potential Game Changers
While treatment for HIV infection has become more effective and less complicated in recent years, it still involves taking a pill or pills each day for life. But innovative new products could revolutionize HIV treatment and prevention. Sometimes called long-acting agents, these products may take different forms, ranging from injections to implants to oral medications, and they would not require daily dosing. Some might require a monthly dose, while others could be administered a few times a year.
Taking an idea and turning it into a desirable, effective, affordable, and accessible product is a long and difficult process. To facilitate the analysis and policy decisions needed to advance the process, amfAR has produced a series of reports that describe the critical issues that must be navigated to make these potentially game-changing new products available for people living with HIV or vulnerable to infection.
